The Goldman Sachs Group Increases ArriVent BioPharma (NASDAQ:AVBP) Price Target to $38.00
ArriVent BioPharma (NASDAQ:AVBP – Free Report) had its target price hoisted by The Goldman Sachs Group from $28.00 to $38.00 in a research note published on Tuesday morning, Benzinga reports. The firm currently has a buy rating on the stock. Other equities research analysts have also issued reports about the stock. Oppenheimer reiterated an outperform […]
More Stories
10 Best Animated Movies that You Can Binge-Watch on Netflix
Are you also an animation movie lover, just like me? Here, in this blog, I have mentioned some of the...
8 Best K-Dramas on Netflix for Beginners to Binge-Watch on the Weekend
Lots of Korean dramas, but confused about which one you should watch? Here, in this blog, I will share my...
Is Running Point Season 3 Coming? Release Date, Production Status, and Cast Members
Running Point is an American sports comedy series that first premiered in 2025 on Netflix. The must-watch comedy sports series...
Is 1670 Season 3 Renewed? Release Date, Cast, and Episodes
The troublemaker Jan Pawel Adamczewski is returning with more silliness, conflicts, and uprisings in 1670, Season 3. This is a...
Know about Disney’s Hexed: Release Date and Trailer
The teaser for the upcoming Disney film, Hexed, is out. Want to know more? Keep reading. Fawn Veerasunthorn, the creator...
Restaurant Fit-Out Planning Tips for Comfort, Flow and Durability
A restaurant fit-out is really juggling two jobs at the same time. It has to make guests feel like they’ve...